Projects per year
Personal profile
Biography
I am leader of the neuropathology and cell biology team, part of the large MND gene discovery program at the Centre for MND Research. I Received my PhD from the University of Queensland in Molecular and Cellular Pharmacology and undertook my first postdoc training at the ANZAC Research Institute, University of Sydney in Prof Ian Blair's group. There I was awarded a Bill Gole Fellowship from MND Research Australia to unravel the cell biology of MND. In 2010, I relocated to Macquarie University with Prof Ian Blair's group as a founding member of the centre for MND Research. I established the neuropathology and cell biology program where I investigated the molecular and cellular changes associated with novel and known MND proteins in patient-derived cells and post-mortem tissues. This work has led to several high impact publications and grants that can be found under the 'Research outputs' section.
Research interests
Gene mutations are the only proven cause of MND and these mutations provide us with the best tools to unravel the fundamental biology of disease. My team has extensive experience in idenifying the functional and pathological changes associated with novel and known MND-linked genes, including TARDBP, OPTN, UNQLN2, PFN1, repeat expansions in C9orf72, CCNF, CHCHD10 and hnRNPs. My program, part of the MND Research Centre's ambitious gene discovery pipeline, validate causal MND genes using pathological and cell biology strategies. The following projects are available in my team: 1) Functional validation of aberrant repeat expansion in ATXN2 and other novel MND candidate genes in an Australian MND family; 2) Neuropathological and analysis of novel and known MND proteins; 3) Targeting mitochondria as a novel therapeutic strategy for MND.
Teaching
I am the co-convenor of MEDI2301-Cellular and Molecular Neuroscience. The goal of this unit is to deliver general and specific aspects of the morphogenesis and function of neurons and glial cells and the dysfunction of the nervous system after injury and in disease. I am also a guest lecture of an equivalent third-year biochemistry and cell biolog subject MEDI3200 -Translational Biology and Genomics (formerly known as MEDI304-Advanced Clinical Science) which is a compulsory unit in the Bachelor of Clinical Science degree.
Fingerprint
- 1 Similar Profiles
Network
-
CMNDR: Macquarie University Centre for Motor Neuron Disease Research
Atkin, J., Blair, I., Rowe, D., Atkin, J., Chung, R., Guillemin, G., Laird, A., Lee, A., Morsch, M., Shi, B., Williams, K. & Yang, S.
1/01/20 → 31/12/22
Project: Other
-
Advanced protein quantification capability
Walker, A. K., Lee, A., Connor, M., Atkin, J., Lim, E., Baker, M. S., Rizos, H., Phillips, J. K., Yang, S. & Blair, I.
1/01/17 → …
Project: Research
-
Revealing the role of protein clearance pathways in sporadic ALS
Chung, R., Lee, A., Rayner, S. & Yang, S.
1/05/19 → 30/04/20
Project: Research
-
MNDRIA_Grant: Assessing the pathogenic role of novel MND candidate genes
26/06/18 → 29/09/18
Project: Other
Research Outputs
-
TDP-43 is a ubiquitylation substrate of the SCFcyclin F complex
Rayner, S. L., Yang, S., Farrawell, N. E., Jagaraj, C. J., Cheng, F., Davidson, J. M., Luu, L., Redondo, A. G., Rábano, A., Borrego-Hernández, D., Atkin, J. D., Morsch, M., Blair, I. P., Yerbury, J. J., Chung, R. & Lee, A., 1 Jun 2022, In: Neurobiology of Disease. 167, p. 1-11 11 p., 105673.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Citation (Scopus)10 Downloads (Pure) -
ALS/FTD-causing mutation in cyclin F causes the dysregulation of SFPQ
Rayner, S. L., Cheng, F., Hogan, A. L., Grima, N., Yang, S., Ke, Y. D., Au, C. G., Morsch, M., De Luca, A., Davidson, J. M., Molloy, M. P., Shi, B., Ittner, L. M., Blair, I., Chung, R. S. & Lee, A., 1 Jun 2021, In: Human Molecular Genetics. 30, 11, p. 971-984 14 p.Research output: Contribution to journal › Article › peer-review
6 Citations (Scopus) -
Splicing factor proline and glutamine rich intron retention, reduced expression and aggregate formation are pathological features of amyotrophic lateral sclerosis
Hogan, A. L., Grima, N., Fifita, J. A., McCann, E. P., Heng, B., Chan Moi Fat, S., Wu, S., Maharjan, R., Cain, A. K., Henden, L., Rayner, S., Tarr, I., Zhang, K. Y., Zhao, Q., Zhang, ZH., Wright, A., Lee, A., Morsch, M., Yang, S., Williams, K. L. & 1 others, , Dec 2021, In: Neuropathology and Applied Neurobiology. 47, 7, p. 990-1003 14 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Unbiased label-free quantitative proteomics of cells expressing amyotrophic lateral sclerosis (ALS) mutations in CCNF reveals activation of the apoptosis pathway: a workflow to screen pathogenic gene mutations
Cheng, F., Luca, A. D., Hogan, A. L., Rayner, S. L., Davidson, J. M., Watchon, M., Stevens, C. H., Muñoz, S. S., Ooi, L., Yerbury, J. J., Don, E. K., Fifita, J. A., Villalva, M. D., Suddull, H., Chapman, T. R., Hedl, T. J., Walker, A. K., Yang, S., Morsch, M., Shi, B. & 4 others, , 27 Apr 2021, In: Frontiers in Molecular Neuroscience. 14, p. 1-18 18 p., 627740.Research output: Contribution to journal › Article › peer-review
Open AccessFile4 Citations (Scopus)11 Downloads (Pure) -
Amyotrophic lateral sclerosis-linked UBQLN2 mutants inhibit endoplasmic reticulum to Golgi transport, leading to Golgi fragmentation and ER stress
Halloran, M., Ragagnin, A. M. G., Vidal, M., Parakh, S., Yang, S., Heng, B., Grima, N., Shahheydari, H., Soo, K-Y., Blair, I., Guillemin, G. J., Sundaramoorthy, V. & Atkin, J. D., Oct 2020, In: Cellular and Molecular Life Sciences. 77, 19, p. 3859-3873 15 p.Research output: Contribution to journal › Article › peer-review
11 Citations (Scopus)